期刊文献+

胰腺癌神经浸润机制研究新进展 被引量:4

New progress in the study of the mechanism of perineural invasion in pancreatic cancer
下载PDF
导出
摘要 胰腺癌机制复杂,致死率高,至今其疗效仍较差,5年生存率极低。胰腺癌中PNI发生率高,是造成胰腺癌术后局部复发的主要因素,是胰腺癌不良预后因素之一。然而,胰腺癌PNI发生的分子生物学原因仍然不清楚,胰腺组织及周围具神经纤维丰富,是胰腺癌PNI的发生发展的解剖学基础。胰腺癌生长的微环境,癌组织介导的神经重塑,都可能是肿瘤细胞PNI的原因。胰腺癌乏氧微环境、慢性炎性微环境以及高糖微环境的协同作用,形成了复杂的网络调控作用,肿瘤基质及肿瘤微环境的网络调控,使神经与肿瘤细胞之间的相互作用发生和形成了PNI。 Pancreatic cancer is characterized by complex mechanism, high mortality rate, poor treatment effect,and low 5-year survival rate. Perineural invasion(PNI) has a high incidence rate in pancreatic cancer, and it was the main cause of pancreatic cancer after operation. PNI is one of the independent factors of poor prognosis in pancreatic cancer. However, the molecular mechanism of PNI is not clear at present. Abundant nerve fibers in the pancreas gland are the anatomical basis of the occurrence and development of PNI in pancreatic cancer. The microenvironment of tumor growth and the organization of the nerve remodeling mediated by tumor tissue may be the cause of PNI of tumor cells.The synergistic effect among the hypoxic microenvironment of pancreatic cancer, inflammatory microenvironment and high glucose microenvironment forms a complex network regulation and control function. PNI occurs and forms in the interaction between nerve and tumor cells in the tumor stroma and tumor microenvironment.
出处 《海南医学》 CAS 2016年第20期3370-3372,3373,共4页 Hainan Medical Journal
基金 河北省卫计委计划项目(编号:20150457)
关键词 胰腺癌 神经浸润 肿瘤 微环境 Pancreatic cancer Perineural invasion Tumor Microenvironment
  • 相关文献

参考文献8

二级参考文献128

  • 1姚俊,马清涌,王连才,张珉,申素刚.PTN shRNA腺病毒载体的构建及其对大鼠DRGn神经突起的影响[J].细胞与分子免疫学杂志,2007,23(9):797-800. 被引量:3
  • 2Jurgen Weitz, Nuh Rahbari, Moritz Koch, et al. The "artery first" approach for resection of pancreatic head cancer [J ]. J Am Coil Surg,2010,210 (2):e1-4.
  • 3Verbeke C, Leitch D, Menon K, et al. Redefining the R1 resec- tion in pancreatic cancer[J]. Br J Surg,2006,93(10):1232-1237.
  • 4Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections [J]. Ann Surg Oncol,2008,15(6): 1651-1660.
  • 5Yermilov I, Bentrem D, Sekeris E, et al. Readmissions following pancreaticoduodenectomy for pancreas cancer: a popula- tion-based appraisal[J].Ann Surg Oncol, 2009,16( 3 ):554-561.
  • 6Adhama M, Singhirunnusorn J. Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors [J]. Eur J Surg Oncol, 2012,38(4):340-345.
  • 7Gockel I, Domeyer M, Wolloscheck T, et al. Resection of the me- sopancreas (RMP): a new surgical classification of a known ana- tomical space [ J ].World J Surg Oncol,2007,44(5): 1-8.
  • 8Gaedcke J, Gunawan B, Grade M, et al. The mesopancreas is the primary site for R1 resection in pancreatic head cancer: rele- vance for clinical trials[J].Langenbecks Arch Surg, 2010, 395 (4):451-458.
  • 9Moldovan SC, Moldovan AM, Dumitrascu T, et al. The advan- tages of retropanereatic vascular dissection for pancreatic head cancer with portal/superior mesenteric vein invasion: posterior approach pancreatico-duodenectomy technique and the meso- pancreas theory[J]. Chirurgia, 2012, 107( 5): 571-578.
  • 10Manish K Agrawal, Dilip Singh Thakur, Uday Somashekar, et al. Mesopanereas: Myth or Reality?[J].J O P,2010,11(3):230-233.

共引文献57

同被引文献40

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部